389 related articles for article (PubMed ID: 27411305)
21. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
[TBL] [Abstract][Full Text] [Related]
22. In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas.
Balzarotti M; Fontana F; Marras C; Boiardi A; Croci D; Ciusani E; Salmaggi A
Oncol Res; 2006; 16(5):245-50. PubMed ID: 17294805
[TBL] [Abstract][Full Text] [Related]
23. Evolving strategies: future treatment of glioblastoma.
Chamberlain M
Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
[TBL] [Abstract][Full Text] [Related]
24. The expression of nitric oxide synthases in human brain tumours and peritumoral areas.
Bakshi A; Nag TC; Wadhwa S; Mahapatra AK; Sarkar C
J Neurol Sci; 1998 Mar; 155(2):196-203. PubMed ID: 9562267
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
26. Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.
Yao XH; Liu Y; Chen K; Gong W; Liu MY; Bian XW; Wang JM
Int Immunopharmacol; 2011 Dec; 11(12):1961-6. PubMed ID: 21930249
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
28. Targeting NOS as a therapeutic approach for heart failure.
Tang L; Wang H; Ziolo MT
Pharmacol Ther; 2014 Jun; 142(3):306-15. PubMed ID: 24380841
[TBL] [Abstract][Full Text] [Related]
29. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
30. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
31. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia in Gliomas: Opening Therapeutical Opportunities Using a Mathematical-Based Approach.
Martı Nez-González A; Calvo GF; Ayuso JM; Ochoa I; Fernández LJ; Pérez-García VM
Adv Exp Med Biol; 2016; 936():11-29. PubMed ID: 27739041
[TBL] [Abstract][Full Text] [Related]
33. iNOS: a potential therapeutic target for malignant glioma.
Jahani-Asl A; Bonni A
Curr Mol Med; 2013 Sep; 13(8):1241-9. PubMed ID: 23590833
[TBL] [Abstract][Full Text] [Related]
34. Emerging drugs for malignant glioma.
Mason WP
Expert Opin Emerg Drugs; 2008 Mar; 13(1):81-94. PubMed ID: 18321150
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
36. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.
Eyler CE; Wu Q; Yan K; MacSwords JM; Chandler-Militello D; Misuraca KL; Lathia JD; Forrester MT; Lee J; Stamler JS; Goldman SA; Bredel M; McLendon RE; Sloan AE; Hjelmeland AB; Rich JN
Cell; 2011 Jul; 146(1):53-66. PubMed ID: 21729780
[TBL] [Abstract][Full Text] [Related]
37. Influence of salt on subcellular localization of nitric oxide synthase activity and expression in the renal inner medulla.
Sullivan JC; Smart EJ; Pollock DM; Pollock JS
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):120-5. PubMed ID: 17892502
[TBL] [Abstract][Full Text] [Related]
38. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis.
Schulz R; Rassaf T; Massion PB; Kelm M; Balligand JL
Pharmacol Ther; 2005 Dec; 108(3):225-56. PubMed ID: 15949847
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
